BioAtla, Inc. Common Stock (BCAB) is a publicly traded Healthcare sector company. As of May 21, 2026, BCAB trades at $3.44 with a market cap of $6.50M and a P/E ratio of -0.73. BCAB moved -3.36% today. Year to date, BCAB is -82.97%; over the trailing twelve months it is -81.51%. Its 52-week range spans $3.26 to $126.25. Rallies surfaces BCAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
BCAB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BCAB recently traded at $3.44. Market cap is $6.50M. P/E ratio is -0.73. Revenue is $2.00M.
| Metric | Value |
|---|---|
| Price | $3.44 |
| Market Cap | $6.50M |
| P/E Ratio | -0.73 |
| EPS | $-4.97 |
| Dividend Yield | 0.00% |
| 52-Week High | $126.25 |
| 52-Week Low | $3.26 |
| Volume | 20 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.00M |
| Net Income | $-50.62M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $2.00M | $-59.61M | $-1.01 |
| 2024 | $11.00M | $-69.78M | $-1.44 |
| 2023 | $0 | $-123.46M | $-2.58 |
| 2022 | $0 | $-106.48M | $-2.74 |
BCAB analyst coverage data. Average price target: $0.00.